2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow quisinostat: new trials by email Literature Review of quisinostat trials Research Report on quisinostat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Quisinostat in High-Risk Uveal Melanoma Quisinostat - Uveal Melanoma | Phase 2 | Recruiting | University of Miami | 63 | 2025-05-27 | 2026-06-18 |
| Safety and Efficacy of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy Quisinostat, Paclitaxel, Carboplatin - Ovarian Cancer | Phase 2 | Completed | NewVac LLC | 31 | 2015-09-01 | 2018-06-27 |
| A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma Quisinostat, 12 mg - Lymphoma, T-Cell, Cutaneous | Phase 2 | Completed | Janssen Research & Development, LLC | 26 | 2011-11-01 | 2016-11-03 |
Lymphoma (1) · Lymphoma, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Ovarian Neoplasms (1) · Uveal Melanoma (1)
Janssen Research & Development, LLC (1) · NewVac LLC (1) · University of Miami (1)
United States (2) · France (1) · Germany (1) · Portugal (1) · Russia (1) · Spain (1) · United Kingdom (1)
Jose Lutzky, MD (1) · Sergei A. Tjulandin, Prof. (1)